Segments Covered
The report on global rheumatology therapeutics market covers segments such as drug class, disease indication, and distribution
channel. The drug class segments include disease modifying anti-rheumatic drugs, nonsteroidal anti-inflammatory drugs,
corticosteroids, uric acid drugs and others. On the basis of disease indication the global rheumatology therapeutics market is
categorized into rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis and others. Furthermore, on the
basis of distribution channel the rheumatology therapeutics market is segmented as hospital pharmacy, retail pharmacy and online
pharmacy.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2016 – 2024. The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia
among others. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region
offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.
The APAC region is projected to experience a healthy growth in terms of CAGR over the period of 2018 - 2024. Among the regions
North America estimated to be the largest market share on accounts of prevalence of rheumatic arthritis in the U.S. and
Canada. Growing healthcare expenditure among the families in the emerging markets such as China, India among others coupled with
increasing geriatric population in the region are likely to drive the growth in the Asia-Pacific region, as a result the Asia-Pacific
rheumatology market is projected to grow at the swiftest CAGR over the forecast period.
Companies Profiled:
The report provides profiles of the companies in the global rheumatology therapeutics market such as, Takeda Pharmaceutical, Sanofi,
Genentech, Inc., Novartis AG, Janssen Biotech, Inc., Amgen, Inc., AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, and Merck &
Co., Inc.
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report